GE HealthCare has received FDA Premarket Authorization for Pristina Recon DL, an innovative 3D mammography reconstruction application. Powered by artificial intelligence (AI), Pristina Recon DL ...
New 3D imaging capabilities of Sonic DL are designed to enable up to 86% i faster scans and enhanced resolution for brain, spine, orthopedic and body imaging. Combination of Sonic DL and AIR Recon DL ...
Sonic DLi is a deep learning (DL) technology that acquires high-quality magnetic resonance (MR) images up to 12 timesii faster than conventional methods, enabling cardiac imaging within a single ...
More than 80 percent of all health system visits include an imaging exam,i making radiology an essential part of diagnostics and healthcare and image quality a cornerstone of medicine. GE HealthCare ...
Exploring the utility of prostate-derived extracellular vesicles as a urine biomarker for clinically significant prostate cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Genitourinary ...
GE HealthCare announced it received FDA 510(k) clearance for its Precision DL deep learning image processing software. Precision DL utilizes deep learning, a subset of AI and machine learning, to ...
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the FDA clearance and launch of Sonic DL – a state-of-the-art deep learning-based technology designed to dramatically accelerate ...